Skip to content
  • Home
  • World News
  • Business
  • Aviation
195 news

195News

All the news that's fit to print

  • Home
  • World News
  • Business
  • Aviation
  • Toggle search form
  • An Outsider Thinking Framework for Professional & Personal Success
    An Outsider Thinking Framework for Professional & Personal Success Business
  • a new model for conservation and enhancement of the planet’s major tropical rainforests
    a new model for conservation and enhancement of the planet’s major tropical rainforests World News
  • Opportunities in AI, Autonomy & Trend Scouting
    Opportunities in AI, Autonomy & Trend Scouting World News
  • Under Secretary Fernandez’s Travel to South Africa
    Under Secretary Fernandez’s Travel to South Africa World News
  • Secretary Antony J. Blinken With Nadia Bilbassy of Al Arabiya
    Secretary Antony J. Blinken With Nadia Bilbassy of Al Arabiya World News
  • Warriors Heart announces Freedom from Addiction Celebration in sync with Independence Day and Month
    Warriors Heart announces Freedom from Addiction Celebration in sync with Independence Day and Month World News
  • Pigmentation Disorder Treatment Market is Projected to Grow Significantly, to Attain a Value of USD 1.2 Billion by 2031
    Pigmentation Disorder Treatment Market is Projected to Grow Significantly, to Attain a Value of USD 1.2 Billion by 2031 Business
  • Secretary Mayorkas Extends and Redesignates Somalia for Temporary Protected Status for 18 Months
    Secretary Mayorkas Extends and Redesignates Somalia for Temporary Protected Status for 18 Months World News
Inmedix appoints Lucy Lu as CCO as it approaches US commercialization.

Inmedix appoints Lucy Lu as CCO as it approaches US commercialization.

Posted on January 24, 2024 By NewsEditor

Inmedix appoints Lucy Lu as CCO as it approaches US commercialization.

Longstanding commercial medtech and diagnostic experience added to the Inmedix executive team

NORMANDY PARK, WA, USA, January 20, 2024 /EINPresswire.com/ — Seattle-based medtech/biotech Inmedix, Inc., developers of immuno-autonomics and cloud-based clinical diagnostics to quantify stress biology with precision, announced today the appointment of Lucy Lu as its Chief Commercial Officer (CCO).

Lucy Lu has more than 25 years of biotech industry experience and has been a consultant to Inmedix since 2020. She most recently served as the President of North America Operations for Syncell, Inc., a biotech startup with an innovative spatial biology platform technology. From 2008 to 2014, Lucy served as SVP of Corporate and Business Development at Crescendo Bioscience. During her six years at Crescendo, she helped raise $90M in venture funding, supported the development and commercialization of a novel rheumatoid arthritis biomarker test, Vectra DA, until Crescendo’s acquisition by Myriad Genetics in 2014.

Prior to joining Crescendo, Lucy was Vice President of the US Chief Technology Office at Roche Diagnostics and was responsible for global technology scouting and assessment to support Roche Diagnostics portfolio growth. In her early career, Lucy worked on drug development at Genentech and BMS before switching to market novel life science tools at Applied Biosystems.

“I am thrilled to join Inmedix as Chief Commercial Officer, and excited to be working with a dynamic team that Dr. Holman has assembled to provide this innovative device to advance patient care,” said Ms. Lu. “By equipping healthcare professionals with this state-of-the-art tool they need, we will empower them to use our real-time data to better monitor their patients’ complex chronic conditions and devise personalized treatment plans to improve health outcomes.”

Inmedix is defining the emerging medical field of immuno-autonomics: the interface between immune function and stress biology, controlled within the brain by the autonomic nervous system (ANS). The natural stress response can beneficially impact immune function in the near term (1). However, chronic activation of the immune system by stress, mediated by the ANS, has been implicated in adversely affecting the onset and severity of autoimmune disease (2). With its CloudHRV™ diagnostic in development, Inmedix intends to provide the leading, precision tool to quantify ANS stress state to support research and clinical care.

“In 2020, Inmedix Board Director and former Crescendo Bioscience President Bernie Tobin introduced me to Lucy,” said Inmedix CEO & Co-founder Andrew J Holman, MD. “Her keen insight, thoughtful leadership and deep experience in the diagnostic field were immediately apparent. As a consultant to Inmedix since that time, her guidance to me and our growing, exceptional team has been pivotal. I could not be more pleased to have her leading our commercial efforts.”

References
1. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES. The sympathetic nerve – an integrative interface
between two supersystems: the brain and the immune system. Pharmacol Rev 2000;52:595-
638.
2. Taylor PC, Holman A J. Rheumatoid arthritis and the emergence of immuno-autonomics.
Rheumatology (Oxford). 2019 Dec 1;58(12):2079-2080. doi: 10.1093/rheumatology/kez216. PMID:
31177267.

About Inmedix, Inc. and its subsidiary, Inmedix UK, Ltd.

Seattle-based biotech/medtech Inmedix, Inc. and its subsidiary Inmedix UK, Ltd., are committed to engaging in world class research to discover innovative solutions for pressing healthcare needs related to the impact of stress, modulated within the brain by the autonomic nervous system (ANS). The Inmedix® CloudHRV™ diagnostic system is leading the development of heart rate variability (HRV) as a potentially informative diagnostic, therapeutic, digital health, and health economic tool. ANS profile may be the most overlooked element of personalized, precision medicine.

NOTICE:

This press release contains certain forward-looking statements, including without limitation statements regarding Inmedix’s plans for preclinical studies and product capabilities. You are cautioned that such forward-looking statements are not guarantees of future performance and involve risks and uncertainties inherent in Inmedix’s business which could significantly affect expected results, including without limitation, progress of development, clinical testing and regulatory approval, developments in raw material and personnel costs, and legislative, fiscal, and other regulatory measures. All forward-looking statements are qualified in their entirety by this cautionary statement, and Inmedix undertakes no obligation to revise or update any forward-looking statement to reflect events or circumstances after the issuance of this press release. This is not an offer to sell or an offer to purchase securities.

Andrew Holman
Inmedix Inc.
+1 2064125347
email us here

You just read:

News Provided By

January 20, 2024, 22:18 GMT


EIN Presswire’s priority is source transparency. We do not allow opaque clients, and our editors try to be careful about weeding out false and misleading content.
As a user, if you see something we have missed, please do bring it to our attention. Your help is welcome. EIN Presswire, Everyone’s Internet News Presswire™,
tries to define some of the boundaries that are reasonable in today’s world. Please see our
Editorial Guidelines
for more information.

Article originally published on www.einpresswire.com as Inmedix appoints Lucy Lu as CCO as it approaches US commercialization.

Business

Post navigation

Previous Post: War Day 553: Hits on Russian Pskov Base and 7 more targets
Next Post: U.S. Hispanic Business Council Celebrates Chairman Roger Williams’ Steadfast Support for American Small Business

Related Posts

  • Verijet Receives Agents for Change Green Travel Award at Sustainable Development Goals Gala for United Nations Assembly Week
    Verijet Receives Agents for Change Green Travel Award at Sustainable Development Goals Gala for United Nations Assembly Week Business
  • Noble Capital Markets Initiates Equity Research Coverage on Commercial Vehicle Group (CVG)
    Noble Capital Markets Initiates Equity Research Coverage on Commercial Vehicle Group (CVG) Business
  • Professor and Author Sanford Moskowitz to be Featured on Close Up Radio
    Professor and Author Sanford Moskowitz to be Featured on Close Up Radio Business
  • New Data From InnoLead Shows Nearly 70 Percent of Respondents at Large Corporations Expect Startup Engagement Activity to Increase in 2023
    New Data From InnoLead Shows Nearly 70 Percent of Respondents at Large Corporations Expect Startup Engagement Activity to Increase in 2023 Business
  • “Transitioning Furniture Business Online” – Omnichannel Specialists YRC Explain Why
    “Transitioning Furniture Business Online” – Omnichannel Specialists YRC Explain Why Business
  • Global Restorative Dentistry Market Is Projected To Grow At A 7.2% Rate Through The Forecast Period
    Global Restorative Dentistry Market Is Projected To Grow At A 7.2% Rate Through The Forecast Period Business
October 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
« Sep    
last celebrity gossip
Gossip Stone - celebrity life and gossip

Recent Posts

  • On Period Action Day, CA nonprofit helped fight Period PovertyOctober 31, 2025
  • Blacksun Unveils $7B Fund and Global Sports Ventures: WAFL & Knockout FightsOctober 31, 2025
  • Xerafy and Impinj Launch the World’s Thinnest Gen2X On-Metal RAIN RFID LabelOctober 31, 2025
  • Japanese Independent Artist NISHIOKA Reaches #15 on U.S. iTunes Singer/Songwriter Chart and #7 on U.K. ChartOctober 30, 2025
  • Serenity Blue by Kris Lin Wins Silver in A’ Interior Design AwardsOctober 30, 2025
Brand Values Content
VUGA Enterprises - media network PR & Marketing
  • Johnson County’s Residential Properties Have Seen A Remarkable 12.6% Jump In The 2024 Reassessment!
    Johnson County’s Residential Properties Have Seen A Remarkable 12.6% Jump In The 2024 Reassessment! Business
  • Capital Industries Announces the Launch of KwikBond’s Online Concrete Repair Guides
    Capital Industries Announces the Launch of KwikBond’s Online Concrete Repair Guides World News
  • War Day 523: Ukrainian Military Intensifies Operations in the South
    War Day 523: Ukrainian Military Intensifies Operations in the South World News
  • War in Ukraine, Analytics. Day 964: West Left Only One Path Forward for Ukraine. Arestovych, Feldman
    War in Ukraine, Analytics. Day 964: West Left Only One Path Forward for Ukraine. Arestovych, Feldman World News
  • Global Marble Market To Reach .03 Billion By 2028 With A Growth Rate Of 9.5%
    Global Marble Market To Reach $50.03 Billion By 2028 With A Growth Rate Of 9.5% Business
  • TELF AG Reports that Livista Energy Europe is set to Build Low-Carbon Lithium Refinery in Germany
    TELF AG Reports that Livista Energy Europe is set to Build Low-Carbon Lithium Refinery in Germany World News
  • Nordzypern wird als Auswanderungsziel immer beliebter
    Nordzypern wird als Auswanderungsziel immer beliebter World News
  • First Platform for Authentic Reviews on Places, Products, and Services Nationwide
    First Platform for Authentic Reviews on Places, Products, and Services Nationwide World News
aerospace company
stem cell clinic in kiev
medical spa in miami
Fashion TV free

Copyright © 2023 195 News. All Rights Reserved by Coolaser | Partner of VUGA Enterprises |  Advertising: Get Published

Powered by .